The role of monocytes in the regulation of GVHD after allogeneic stem cell transplantation.
The role of monocytes in the regulation of GVHD after allogeneic stem cell transplantation.
批准号:
11670976
负责人:
TANAKA Junji
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Although granulocyte colony-stimulating factor (G-CSF)-mobillized peripheral blood mononuclear cells (G-PBMC) grafts contain at least ten times more T cells than standard bone marrow grafts, the incidence and severity of acute graft-versus-host disease (aGVHD) is not higher than that observed with allogeneic marrow. We have shown that the induction of constimulatory molecule CD28 responsive complex in CD4+ cells appears to be suppressed by the presence of CD14+ cells in the G-PBMCIt has recently been shown that inhibitory natural killer cell receptors (NKRs) on NK cells negatively regulate NK cell and also T cell functions through their binding to MHC class I molecules. A CD94/NKG2 heterodimer serves as a receptor for HLA-E non-classical HLA-I molecules. We showed the expression of CD94/NKG2A on T cells was higher in cGVHD patients with good response to conventional immunosuppressive therapy than in cGVHD patients with poor response. Also, we reported the increased expression of CD94/NKG2A on CD8+ T cells in G-PBMC after mixed lymphocyte culture (MLC). However, CD94/NKG2A expression did not increase when CD14-depleted G-PBMC was used. The addition of purified CD14+ cells to CD14-depleted G-PBMC induced CD94/NKG2A expression in a dose-dependent fashion, however, this enhancing effect of purified CD14+ cells on CD94/NKG2A expression was inhibited by the presence of a membrane between responder cells and CD14+ cells. Therefor, CD14+ cells in G-PBMC induce CD94/NKG2A expression on CD8+ T cells, which in turn appear to down-regulate alloresponses. Therefore, inhibitory NKR expression on T cells has an important role in the regulation of alloresponse.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tanaka J et al.: "Sequential analysis of HLA-C-specific KIR (CD158b) expressing PBMC during chronic GVHD"Bone Marrow Transport. 26. 287-290 (2000)
Tanaka J 等人:“慢性 GVHD 期间表达 PBMC 的 HLA-C 特异性 KIR (CD158b) 的序列分析”骨髓运输。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka J. et al.: "Increased expression of HLA class I specific KIR(CD94) on PBMC after allo BMT"Acta Haematol. 105. 89-91 (2001)
Tanaka J. 等人:“异基因 BMT 后 PBMC 上 HLA I 类特异性 KIR (CD94) 的表达增加”Acta Haematol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka, J., et al.: "T cell cosignaling molecules in GLHD"Ann Hematol. (in press).
Tanaka, J. 等人:“GLHD 中的 T 细胞协同信号分子”Ann Hematol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka J et al.: "Increased expression of HLA class I specific KIR (CD94) on PBMC after allo BMT"Acta Haematol. 105. 89-91 (2001)
Tanaka J 等人:“异基因 BMT 后 PBMC 上 HLA I 类特异性 KIR (CD94) 的表达增加”Acta Haematol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka J et al.: "OKcells expressing KIR after allogeneic BMT."Transplant. Proc.. 32. 2447 (2000)
Tanaka J 等人:“同种异体 BMT 后 OK 细胞表达 KIR。”移植。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 22 条
Expansion of activated NK cells from cord bloood
-
批准号:22591056
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:TANAKA Junji
-
依托单位:
Transient receptor potential A1 mediates gastric distention-induced visceral pain in rats
-
批准号:21590798
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:TANAKA Junji
-
依托单位:
Expansion of inhibitory NK cell receptor-expressing CD8 T cells and immunoregulatory CD4 T cells
-
批准号:19591093
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:TANAKA Junji
-
依托单位:
Visceral pain and activation of MAPK in sensory neurons after noxious gastric distension
-
批准号:19590740
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:TANAKA Junji
-
依托单位:
Research for cell therapy using NK cell receptor-expressing T cells against leukemia.
-
批准号:17590975
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:TANAKA Junji
-
依托单位:
Allogeneic cell therapy for the regulation of GVHD/GVL
-
批准号:15590990
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:TANAKA Junji
-
依托单位:
Possible effect of splenectomy on liver regeneration in cirrhotic rats.
-
批准号:63570629
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1988
-
负责人:TANAKA Junji
-
依托单位:
Experimental studies of latency and persistence in vitro by human cytomegalovirus
-
批准号:61570226
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1986
-
负责人:TANAKA Junji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
索拉非尼通过mtDNA-cGAS-Sting信号轴调控巨噬细胞和NK细胞间的免疫互话增强GVL的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:宣丽
-
依托单位:
Stat3缺失的供者T细胞通过PD1/PD-L1抑制GVHD 保留GVL效应的机
制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨世杰
-
依托单位:
索拉非尼调控移植后骨髓微环境介导巨噬细胞和NK细胞间的免疫互话诱导GVHD与GVL分离的机制研究
-
批准号:82370216
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:宣丽
-
依托单位:
SOCS1抑制T细胞炎症通路降低GVHD保留GVL效应的调控机制研究
-
批准号:82300243
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:郭惠东
-
依托单位:
L-精氨酸逆转异基因造血干细胞移植后AML骨髓微环境NK细胞自噬并恢复GVL效应的机制研究
-
批准号:82370217
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:王冬耀
-
依托单位:
Allo-HSCT后靶向递送IL-15/IL-15Rα上调AML细胞MHC表达分离GVL与GVHD的实验研究
-
批准号:82370220
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:石威
-
依托单位:
高剂量外周血造血干细胞作为移植物应用于小鼠单倍体移植模型对GVHD及GVL作用影响的机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:江明
-
依托单位:
NK细胞在单倍体联合脐血移植模式中诱导GVHD和GVL分离作用及机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:于嗣俭
-
依托单位:
异基因双阴性T细胞抑制移植后aGVHD并保留GVL效应的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:朱小玉
-
依托单位:
ADAM10调控小鼠allo-HSCT后GVHD和GVL的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:陈翀
-
依托单位: